Related Experiment Video

Updated: Jan 9, 2026

Pulmonary Embolism III: Nursing Management
01:27

Pulmonary Embolism III: Nursing Management

Published on: June 19, 2025

320

Targeted manipulation of apoptosis in cancer treatment

Justin A Call1, S Gail Eckhardt, D Ross Camidge

  • 1Developmental Therapeutics and Gastrointestinal Malignancies Programs, University of Colorado Comprehensive Cancer Center, Aurora, CO, USA.

The Lancet. Oncology
|September 2, 2008
PubMed

Insights

Targeting apoptosis, programmed cell death, offers new cancer treatment strategies. Manipulating apoptosis pathways can overcome therapeutic resistance and promote cancer cell death, with novel drugs in clinical trials.

Area of Science:

  • Cell Biology
  • Oncology
  • Pharmacology

Background:

  • Apoptosis is crucial for multicellular organism development and maintenance.
  • Dysregulation of apoptosis is a hallmark of human cancers.
  • Cancer treatments like radiotherapy and chemotherapy often induce apoptosis, but resistance is common.

Purpose of the Study:

  • To review the rationale for directly targeting apoptosis in cancer therapy.
  • To describe novel agents designed to manipulate apoptosis for cancer treatment.
  • To highlight agents currently in early-phase clinical trials.

Main Methods:

  • Literature review of apoptosis regulation in cancer.
  • Summary of preclinical and clinical data on apoptosis-modulating agents.
  • Analysis of therapeutic strategies targeting apoptosis pathways.

Main Results:

  • Resistance to apoptosis contributes to therapeutic cross-resistance in cancer.
  • New drugs targeting apoptosis are being developed.
  • Several novel apoptosis-targeting agents are in early clinical trials across various cancer types.

Conclusions:

  • Directly manipulating apoptosis holds promise for overcoming cancer treatment resistance.
  • Targeting apoptosis offers a rational approach to developing new anticancer therapies.
  • Ongoing clinical trials will determine the efficacy of these novel agents.

More Related Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Published on: June 19, 2025

277
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Published on: June 19, 2025

464

Related Concept Videos

Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K